Ubiquitination of proteins such as MYCN and p53 has been shown to be important in neuroblastoma pathogenesis [12–14], and the pathways regulating ubiquitination have been identified as candidate therapeutic targets in neuroblastoma cells and tumors [15–20]. The gene discussed is MYCN; the disease is neuroblastoma.